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Abstract
The paper describes illegal substance abuse by inmates in prisons in the Czech 
Republic and gives the readers information about the results of initial research on 
this hardly avoidable issue. The paper brings interesting findings in this field and 
describes new ways of prevention and treatment, which is dealt with by prison 
directorates not only in the Czech Republic.
Keywords: prisons, detoxification units, illegal substance, drug policy, therapeutic 
communities
1. Introduction
Initial research work focusing on the issue of illegal addictive substance abuse in 
Czech prisons started to emerge in the first half of 1990s. Interesting were the results 
of one of the first researches done in 1992 where the authors found out that the 
age structure of addicted prison inmates and the other inmates did not differ. The 
authors estimate that the total number of illegal drug users is around 4% but some 
internal sources say 6% because only the users who met the addiction criteria based 
on international classification were included in the basic file, i.e. those who showed 
the signs of addiction only in terms of medicine, which is only one of many possible 
aspects of illegal drug use [1]. As far as the spectrum of substances used is con-
cerned, stimulants, benzodiazepines, cannabinoids and opioids dominate distinctly. 
Then barbiturates, amphetamines, cocaine and THC. If we tried to divide a group of 
prison inmates into groups based on drugs used, the order would be as follows:
a. Juveniles – marihuana, methamphetamine, hashish, Rohypnol, inhalants, 
psilocybin mushrooms, LSD, heroin.
b. Women - methamphetamine, marihuana, Rohypnol.
c. Men - marihuana, methamphetamine, heroin, MDMA (ecstasy).
d. Recidivists - marihuana, methamphetamine, heroin, hashish, MDMA, LSD, 
cocaine, ephedrine, psilocybin mushrooms, Rohypnol.
Drug use in prison takes all forms including smoking, snuffing, swallowing, 
sniffing or intravenous application. There is a lower probability of intravenous 
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application among juvenile criminals than among adults, and in prison population 
there is a higher probability of intravenous application among women than among 
men [2]. Several studies in prisons revealed that about one third of imprisoned 
adult men applied drugs intravenously. A question arises in this respect about the 
access to sterile kits for intravenous application of drugs, hygienic standards and 
possibility of spreading infectious diseases. Pharmaceutical drug addiction repre-
sents a specific category of addiction. These include pharmaceuticals with analgesic, 
hypnotic and anxiolytic effects typical of the population of addicts who are depen-
dent on these medications in the long term. Long-term use may result in psycholog-
ical or somatic dependence. Medications used most frequently include analgesics, 
nonsteroidal anti-inflammatory drugs and hypnotics (e.g. Rohypnol) [3].
2. Users of illegal substances in prisons
There are many individuals in prisons who used illegal addictive substances – 
drugs – before they were imprisoned [4]. Up to 75% of them admitted to com-
mitting crime in order to get drugs or money to buy them. Statistical Yearbook 
2010 of the Czech Republic Prison Service states that the total number of drug 
addicts registered by the medical service was 10,763. If this number means the 
lifelong prevalence of drug use, we could say that it is almost 50% in prison 
population. However, we cannot say that almost every other prison inmate is 
a drug addict. In 2010, there was a representative study conducted in prison 
population with the involvement of the Prison Service of the Czech Republic and 
National Monitoring Center for Drugs and Drug Addiction. Data was collected in 
all prisons from a sample of inmates, which amounted to 2,000 people. Based on 
the results of existing studies, experience from abroad and qualified estimates, 
we can suppose that the drug use in prison population is significantly higher 
than in general population. Many times the prison inmates learn to use drugs 
when they are imprisoned. Prison staff tries to prevent the inmates from using 
drugs, but despite that the drug abuse in prison is still increasing. Before 1989, 
various pharmaceutical drugs were also abused in Czech prisons. Some penolo-
gists, doctors, psychologists but also prison psychiatrists use the term pharma-
cophobia, which means literally “using and fighting against” pharmaceutical 
drugs. For example, medications like Dinyl, Algena, Solutan, Spasmoveralgin 
or Sedolor or Phenobarbital were popular in prison history especially in 
1970s. Then in 1990s, so-called benzodiazepines got ahead; namely Rohypnol, 
Diazepam, Alnagon, Nitrazepam or Oxazepam and many other medications 
were popular. If a prison doctor gives the prison inmates too many medications 
simultaneously - this phenomenon is called polypharmacy – it can easily lead to 
pharmaceutical drug abuse. However, drug addicts in prison currently try to get 
hard drugs into prison or possibly even make them there. Less appropriate terms 
are sometimes used for drug addiction like narcomania or toxicomania; a more 
modern term is use, which means drug use in acceptable quantity, and abuse or 
misuse or overuse of drugs associated with addiction. Drug addicts in prison 
are medically registered and the prison staff should safeguard their abstinence 
regimen. Medications that are given to prison inmates must be prescribed only 
by doctors, and only supervising officers or healthcare staff may dispense them. 
The basic condition for effective treatment of prison inmates is a quality prepa-
ration of this activity. First, it is necessary to map the inmate’s initial condition 
at the beginning of imprisonment. This is done with the team cooperation of 
a doctor or other specialists, a psychologist, special education teacher, social 
worker or a priest [5].
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3. Drug policy of the Czech Republic prison service
Drug policy of CR PS is governed by a regulation. This regulation stipulates 
the application of drug policy of CR PS, sets rules, organization, record-keeping, 
methods and forms of treatment of inmates who have a history of substance abuse, 
including narcotics and psychotropic substances or their precursors, and people 
who have no drug history but they can be considered endangered by them [6].
The PS drug policy is implemented by the following specialized wards estab-
lished in detention facilities and prisons:
a. Drug prevention center,
b. Drug-free zone with standard regimen,
c. Drug-free zone with therapeutic regimen,
d. Specialized ward for compulsory treatment whose function is governed by the 
internal regulation.
e. Specialized ward for care of inmates with personality disorders or behavioral 
disorders caused by substance abuse, whose function is governed by the 
internal regulation [7].
4. Care for drug Addicts in prisons
There are drug-prevention centers in prisons, standard and therapeutic drug-free 
zones are available, and drug users get treatment including detox and substitution 
therapy. This function is provided by the CR Prison Service.
5. Drug services in prisons
Services of prevention, therapy and aftercare for drug users started to develop 
in the Czech Republic in 1990. At the end of 1990s, there was a relatively compre-
hensive system of preventive programs. Communication with prison managements 
started to develop and first projects started to emerge, focusing exclusively on 
working with clients in prisons. There are 36 prisons in the Czech Republic, includ-
ing detention facilities. Nine of these places offer methadone therapy to prison 
inmates. A few years ago, 15 non-profit organizations provided their services in 30 
prisons and detention facilities. Their work consisted in health-oriented interven-
tions, including addiction counseling and drug addiction therapy, and also in the 
preparation of prison inmates for their release, and in arranging for aftercare upon 
release. General Directorate of the CR Prison Service has an “action plan in drug 
policy” in place, which in one of its parts focuses particularly also on the area of 
harm reduction. There are drug-prevention centers in prisons, drug-free zones are 
available and drug users get therapy including detox and substitution therapy. They 
are provided by the Prison Service (hereinafter PS) and many of the services are 
also provided by non-profit organizations. Measures taken by PS are divided into 
3 areas. In the area of drug supply reduction, beside drug addiction monitoring, 
creation of drug-free zones and preventive medical examinations, stress is put 
mainly on the analysis of medical records, performance of initial medical examina-
tions in order to find clues of drug application and on making the indication and 
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administration of addictive medications more restrictive. As far as primary preven-
tion is concerned, there are antidrug programs, initial training courses for new 
prison staff and regular in-service training for healthcare staff. As far as secondary 
and tertiary prevention is concerned, the prison service staff takes upgrade train-
ing courses and drug prevention centers are established. The important fact is that 
prison inmates have the same right to healthcare access as the rest of the population, 
including assistance and therapy provided to drug users. From the medical, thera-
peutic and educational point of view, there are 4 groups of prison inmates based on 
treatment in prisons:
a. Inmates with no prior drug experience who do not want to get the experi-
ence even in prison. Within the treatment and harm reduction program, 
these inmates should be strictly placed in drug-free zones with a zone model 
designed to protect the group of inmates not using drugs from the drug users.
b. Inmates with no prior drug experience but who are likely to resort to drug 
as one of the possible consequences of imprisonment. For them the drug is a 
means of stress release and dealing with life in a crowded and often violent 
environment. This group, within the treatment and harm reduction program, 
is treated in the same way as the first group but the drug prevention education 
is more intensive.
c. Inmates who used drugs before imprisonment but who are trying to quit. 
Medical and therapeutic system of treatment is applied to these inmates.
d. Inmates who used drugs before imprisonment and who do not want to quit 
even in prison. This could be resolved by separating these inmates from the 
others and try to prevent their smuggling and corruption attempts by all avail-
able legal means.
Other groups may include drug dealers, who do not use drugs, and people who were 
ordered compulsory treatment. Of course the drug availability in prisons is not com-
parable with the availability out of prisons. Different types of treatment do not exclude 
each other but can complement each other and meet different needs of clients. In order 
to provide differentiated approach to serving a sentence, the prison team implements 
several types of antidrug measures and programs. These include the following:
• Detoxification performed in prison hospitals;
• Establishment of so-called drug-free zones and specialized wards where tutors, 
a special education teacher, psychologist, social worker, therapist and a doc-
tor work;
• Programs for the implementation of compulsory drug addiction and alcohol-
ism treatment;
• Drug prevention centers;
• Substitution therapy;
• Harm reduction programs;
• Participation of therapists from the staff of non-profit organizations.
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Upon request of the prison service, the services in prison are currently focused 
on abstinence. For the time being, the harm reduction approach is applied mainly 
in the form of information. Drug services in prisons are provided by non-profit 
organizations. This practice is based on legislative capabilities of interest groups to 
operate in prison [8].
6. Screening
The accused and the convicted are tested for the presence of addictive sub-
stances in the body. One of the reasons is to check compliance with the drug 
prohibition. This information may indicate therapy or other antidrug intervention 
and last but not least it indicates whether the rules of therapy are followed. Two 
basic types of tests are performed, one for reference using a set to detect addictive 
substances or their metabolites in urine, and a confirmation analysis performed 
by an accredited toxicology laboratory mostly using a chromatographic method. 
Possibility of detecting some of the addictive substances in urine:
• Amphetamines: 2–5 days (depending on urine pH)
• Heroine, morphine: 2–5 days
• Cannabis: 2–5 days (occasional user), 10–30 days (chronic user)
• Cocaine: 2–3 days
• LSD: up to 5 days
• Methadone: 14 days
Initial medical examinations of inmates at the start of detention and inmates 
at the start of imprisonment that exceeds 4 months include the test. This is used to 
monitor a probable proportion of drug users in prison population. This testing is also 
used to verify the anamnestic information given by the inmates at the initial medical 
examination and becomes part of the person’s medical records. Another category of 
testing includes randomly systematic testing and so-called targeted testing [9].
7. Detoxification units
Detoxification units are designated for handling withdrawal symptoms and 
intoxication with addictive substances that do not require intensive care in another 
facility, e.g. in an intensive care unit. Detoxification units are most often separate 
units within hospitals or parts of facilities for medium-term or long-term treatment. 
Clients in substitution programs are detoxified most often as outpatients. The target 
group includes namely clients who need to reduce their drug tolerance because of 
their health or social situation but they are not motivated to abstain or to start other 
therapy, then clients who are dangerous to themselves or to their surroundings 
because of intoxication or withdrawal symptoms, or possibly clients for whom it is 
necessary to distinguish between intoxication and mental illness. The detoxifica-
tion units should provide pharmacologic treatment of states of acute intoxica-
tion, withdrawal syndrome and somatic complications. Detoxification includes 
overall assessment of client’s condition, and laboratory testing, pharmacotherapy, 
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psychotherapy, social work and structured program are used. Withdrawal symp-
toms when opiates and opioids are withdrawn often look dramatic. As the opioid 
withdrawal symptoms make the patient crave the drug, the patient often overacts 
the signs and symptoms in order to get higher doses of medications. Clinical symp-
toms are often compared to those of flu as far as appearance and severity are con-
cerned. Opiates and opioids with longer biological half-life cause longer and milder 
withdrawal state, while opioids with shorter half-life cause short withdrawal state 
but with more severe symptoms. The withdrawal state upon withdrawal of heroin 
and morphine usually starts 6–8 hours after the last dose, it peaks on the second and 
third day and lasts approximately 7–10 days. The withdrawal state upon methadone 
withdrawal starts 1–3 days after the last dose and lasts one to three weeks. The most 
standard detoxification methods:
1. Detoxification by methadone;
2. Detoxification by clonidine;
3. Detoxification by buprenorphine; Symptomatic detoxification - combination 
of Diazepam, beta blocker, spasmolytic (e.g. Algifen);
4. Detoxification without medication, a so-called “dry method” - based on an as-
sumption that the memory of unpleasant withdrawal without medication will 
prevent relapse [10].
8. Drug counseling center of the Czech Republic prison service
A drug counseling center, which is established in all prisons, is an advisory 
body of the prison director. The counseling center collects statistical data from the 
antidrug area, deals with the issues in the area of drug abuse prevention, includ-
ing treatment of users and non-users in terms of general principles of safety and 
treatment of people placed in detention facilities and prisons. The drug counseling 
center is established by a respective prison director.
The staff of the drug counseling center usually consists of specialized prison 
employees such as:
a. Psychologist,
b. Special education teacher,
c. Social worker,
d. Tutor - therapist,
e. Head physician of the healthcare center or other healthcare worker delegated 
by the head physician [11].
9. Drug-free zones
Drug-free zones are established based on Act. No. 169/1999 Sb., Prison Act, and 
based on the internal regulation that stipulates the rules for the establishment and 
functioning of drug-free zones. The goal is to prevent the contact of prison inmates 
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with addictive substances and their users. These zones are separated from the other 
accommodation areas and the above-standard amenities make it possible to apply a 
drug-free regimen and serve differentiated sentences. Only the inmates with no drug 
history who do not want to be exposed to the other users’ pressure are placed there. 
They voluntarily undergo reference testing, which detects the drug presence. The 
drug-free zone is established in order to minimize possible contacts of inmates with 
drugs, to apply drug-free regimen and to enable serving differentiated sentences for 
imprisoned drug users for the sake of reducing health and social risks of their addic-
tion. The drug-free zone in prison is established and disestablished by the managing 
director of penology. The drug-free zone is a separated complex, which includes 
accommodation facilities, culture room, room for self-service activities and possibly 
other facilities such as work rooms, multi-purpose rooms, workstations, dining 
room, walking premises. The inmate is placed in a drug-free zone upon inmate’s writ-
ten request if the established criteria are met and if there is vacancy in the drug-free 
zone. The request includes inmate’s statement in which the inmate undertakes to 
voluntarily follow the rules and principles of behavior stipulated in the drug-free 
zone regulations. The inmate is removed from the drug-free zone if he/she provably 
abused a drug or refused to have his/her abstinence checked or refused to have a body 
fluid sample taken. The inmate is usually removed also for the following reasons:
a. Got a disciplinary punishment,
b. Refused to participate in compulsory activities or repeatedly failed to perform 
under the treatment program,
c. Other serious reasons are found,
d. Asked for removal from the drug-free zone.
In the drug-free zone project, in the individual training plan and in the employ-
ment contract the prison director, upon motion of the detention and imprisonment 
department manager, sets the competence and scope of obligations for each specialized 
employee who treats inmates in the drug-free zone. The goal of placing inmates in the 
drug-free zone is to create conditions for them to abstain in prison. A standard drug-
free zone is usually established in the accommodation area separated from the other 
inmates. The methods and forms of treatment consist in taking standard approach in 
safety, psychology and pedagogy, which affects the inmate’s view of the drug, moti-
vates him/her to abstain, and to have a healthy lifestyle while being in prison as well as 
afterward. The following inmates are placed in a standard drug-free zone:
a. Those who did not use drugs but can be considered endangered by them,
b. Those who used drugs and now are motivated to voluntarily abstain,
c. Those who used drugs prior to going to detention facility or prison and who 
successfully completed a therapeutic and educational program in a specialized 
prison ward for inmates with personality disorders or behavioral disorders 
caused by addictive substance abuse and who currently abstain [12].
10. Therapeutic drug-free zone
A therapeutic drug-free zone is established for the purpose of targeted 
therapeutic and other specialized influence on inmates to achieve abstinence or 
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possibly motivate them to undergo treatment or at least to reduce the harm arising 
from drug use [13]. The therapeutic drug-free zone is established in the accom-
modation area separated from the other inmates. The following inmates are placed 
in the therapeutic drug-free zone:
a. Those who used drugs in the past and are motivated to cooperate in a therapeu-
tic program with the goal to minimize relapse and harm arising from drug use,
b. Those who used drugs prior to going to detention facility or prison, who 
completed treatment or therapeutic and educational program in a specialized 
prison ward for inmates with personality disorders or behavioral disorders 
caused by psychotropic substance abuse and who are interested in additional 
specialized treatment.
11. Treatment of drug addicts in prison
A specialized ward for compulsory drug addiction treatment, alcoholism 
treatment and gambling treatment in a prison for women in Opava was established 
in 1999 and was designated for women with minimum security, medium security 
and high security, while a specialized department for men was established later, 
in 2004, and only for sentenced men with medium security. Placement in this 
department is voluntary or treatment is ordered by court pursuant to Section 351 
of the Criminal Procedure Act with the cooperation of the Directorate-General of 
the Czech Republic Prison Service. An inmate who was placed in the specialized 
department and to whom the court ordered a compulsory treatment, is obligated 
to undergo this compulsory treatment. The length of stay in the specialized 
department for compulsory treatment is based on the therapeutic program; it 
depends on inmate’s personality and performance in the individual treatment 
program. The program is usually planned for a minimum of seven months but the 
stabilization stage may be extended as needed, depending on capacity, to last up to 
one year. One-year stay is usually recommended on average, which means place-
ment of an inmate in the specialized department for drug addicts a year before 
parole or a year before the release from prison. The inmate may be placed in the 
specialized department no sooner than one month upon completion of methadone 
substitution therapy, which also takes place in Opava prison [14]. So the inmate’s 
ongoing methadone substitution therapy is one contraindication for placement 
in this department and the other contraindication is epilepsy. An inmate who was 
ordered a compulsory treatment by court may be placed in the specialized depart-
ment for compulsory treatment while serving a sentence, but also an inmate who 
was not ordered a compulsory treatment by court but the inmate has a provable 
history of addictive substance abuse, including alcohol and gambling and wants 
to undergo this therapeutic program in the specialized department upon request. 
A large number of special therapeutic practices are used. Psychotherapy, practic-
ing, training and education with the use of a regimen component are applied 
when working with inmates. All of these methods are based namely on a positive 
expectation on client’s part, health and illness interpretation, realizing the nega-
tive impact arising from patterns of pathological behavior [15]. Also, the methods 
are based on a therapeutic relationship that includes interest, trust and accep-
tance, but it also strives for support in finding motivation to abstain and creating 
inmates’ own views of the drug addiction harmfulness. Inmates interested in 
longer therapy get it in individual form because the number of such inmates is not 
high enough to always run the therapeutic groups [16].
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12. Therapeutic communities in prisons
Different authors agree that the environment and culture in prison are favor-
able for TC to be used because they bring to the prison environment a completely 
different paradigm than the host institution has. The fact is that the imprisonment 
itself is contrary to the basic principles of TC, mainly the principle of voluntari-
ness and responsibility. The TC model, in contrast with the imprisonment, 
provides a complex of behavioral, cognitive, emotional and relational stimuli that 
lead to a change of self-concept and support maturation and socialization. Thus 
the initial conditions for TC are worse in prisons than anywhere else. In spite 
of these problems, it is possible to establish a community in prison with a high 
degree of joint control and ongoing process of social learning. In the last years, 10 
treatment centers were established in Czech prisons for the treatment of inmates’ 
drug addiction by abstinence. It is based on the standards for residential treatment 
in TC, including the phase format and therapeutic, educational, working and 
leisure-time components of a daily regimen. Efficient TC factors should be used in 
treatment programs as much as possible. Principles of this concept are currently 
applied in at least 4 out of 10 existing treatment centers, which, however cannot 
be confirmed from direct sources of the Czech Republic Prison Service because the 
term “therapeutic community” is not used there [17].
13. Substitution therapy
The principle of the substitution (replacement) therapy is to replace illegally 
gained addictive substances with a substance (medication) that has a longer 
effect, similar properties and effects, with known concentration like the drug 
used, without toxic ingredients and it is applied orally. This type of substance is 
called agonist. This treatment was originally about administering the substance 
that was used, e.g. heroin. The preparations are currently prescribed by a doctor; 
methadone – a synthetic opiate in the form of tincture, and buprenorphine in 
the form of tablets are used most frequently as opiate agonists [18]. Substitution 
therapy of opioid addiction was introduced in the Czech Republic Prison Service 
in 2006 when a pilot project in two prisons started, one in the Detention Facility 
Prague Pankrác and the other in Příbram Prison. After successful completion of 
this pilot project, the substitution therapy was gradually extended to eight other 
prisons where substitution therapy centers were established. The whole project of 
substitution therapy introduction was designed from the very beginning to enable 
implementation under common conditions of our prisons, i.e. under the conditions 
of standard sentence or detention. So no special wards were established where all 
patients undergoing substitution therapy would be jointly placed. Substitution 
therapy in the Czech Republic Prison Service is usually implemented in the form of 
outpatient treatment. The criterion for including an inmate in substitution therapy 
is addiction to substances from the opioid group where the therapy by abstinence 
is impossible or where it was repeatedly unsuccessful. Another criterion is that 
only a prison inmate who is or was undergoing substitution therapy in a healthcare 
facility out of prison may be included in the substitution therapy. So the substitu-
tion therapy is not initiated in prison. Methadone is usually the medication used for 
substitution therapy. Substitution therapy is provided in a total of ten prisons where 
substitution therapy centers are established. The prevalence of infectious diseases 
and namely viral hepatitis B and C is higher in prison population than in normal 
population. Injection drug users are certainly a high-risk group as far as spreading 
of infectious diseases is concerned. The biggest non-governmental service provider 
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for problematic drug users and drug addicts in the Czech Republic is SANANIM, 
which runs not only CADAS but also for example two therapeutic communities, 
a low-threshold center, daycare center, aftercare center or a program of prison 
services and others. The effectiveness or success of therapy does not depend only 
on a given substitution substance but also on the related context and accompanying 
components of the therapy. Psychosocial interventions can contribute significantly 
to the success of the substitution therapy [19].
14. Harm reduction (risk minimization)
The term harm reduction was originally used only in connection with measures 
and programs focused on mitigating the adverse health effects of narcotics and 
psychotropic substances. However, this term is currently used in connection with 
the strategies that contribute to the mitigation of potential health and social risks 
and harm caused by using all types of drugs, including interventions in drug 
supply and demand. The target group is represented by problem or injection drug 
users who are the biggest threat to public health. The basic characteristic of the 
harm reduction model is pragmatism. Instead of trying for absolute elimination of 
drugs and their use, it tries to work with them in a way to minimize the negative 
consequences of such behavior. This approach originated as a response to emerging 
HIV/AIDS, which started to spread among injection drug users. That is why under 
these programs the drug users get the used needles and syringes changed for clean 
ones, they are informed about the principles of less risky drug use, safe sex, etc. 
Introduction of harm reduction into the prison environment is a controversial topic. 
Nevertheless, as proven by the foreign research results, harm reduction in the prison 
environment may significantly contribute to limiting the spread of contagious dis-
eases like HIV/AIDS or hepatitis C (hereinafter VHC). Viral hepatitis C infection is 
widespread among injection drug users. One of the main effects of the “war against 
drugs” is a high number of imprisoned drug users. At the same time, injecting drugs 
remains a widespread phenomenon in prisons. Introduction of the needle change 
program turned out to be an effective measure for harm reduction - minimized 
needle sharing and subsequently the transmission of HIV and VHC among the 
injection users and their sexual partners. A number of countries introduced these 
programs into selected prisons [20].
15. Release from prison and conclusion
The client usually encounters increased stress and challenging period on 2nd or 
3rd day upon release from prison. The foreign experience and also the Czech experi-
ence show that the highest-risk period for criminal recidivism and drug relapse is 
the first 48 hours. These people were used to dealing with all the euphoria, stress 
and problems by taking drugs and it is therefore necessary to help them stabilize. It 
turns out that the plans created in the prison environment have to be adjusted most 
of the time depending on specific conditions of the client upon release from prison 
that were not known at the planning stage. Also, clients’ resolutions, motivation 
and ideas often change and it is necessary to work with it flexibly. It is therefore 
important to take advantage of the trust that formed between the clients and the 
project staff and help the clients manage the highest-risk period of 48 hours after 
the release mentioned above and then at least another 1–2 months with the goal of 
providing effective direct medical and post-penal care. Moreover, these clients are 
double stigmatized. Both by their drug history and by their criminal past, which 
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makes their social inclusion upon release from prison more difficult and deepens 
their social exclusion. It is necessary to realize that hardly any group of people is 
forced to communicate with so many institutions like drug users in conflict with the 
law – police, courts, prison service, medical and contact facilities, probation offi-
cers, etc., whereas each of the institutions has different demands and view of the 
particular person. Antidrug policy of the Prison Service and overall practice of the 
antidrug services for imprisoned drug users have to be perceived as part of a wider 
framework of professional treatment of prison inmates. The fact that a sentenced 
person is addicted to substances or is a drug user may be perceived in penal practice 
from a few aspects. Drug use and related behavior is a serious health risk, i.e. it is a 
behavior that potentially compromises the health of the person but also the person’s 
surroundings. Drug use also represents a serious safety risk as it can be expected 
that the person addicted to substances out of prison will try to get the drug also 
in prison and use it there. One of the main goals of prison systems in developed 
countries is to reduce the criminogenic risk of imprisoned people, specifically to 
reduce the probability that the particular individual, when released from prison, 
will commit the same or even more serious crimes than before the imprisonment. 
The Czech Republic Prison Service thus contributes significantly to the society 
protection by monitoring the situation with imprisoned drug users and mainly by 
offering professional intervention in the area of drug prevention to people at risk, 
i.e. it provides so-called antidrug services to them [21].
16. Results of studies in the Czech republic
According to the research, it was found that addictive substances were used by 
more than half of the respondents during VTOS. These were mostly meth, THC, 
alcohol and benzodiazepines. 18% of respondents mentioned the method of inject-
ing addictive substances in prison and 9% of respondents stated the sharing of appli-
cation aids. According to the majority of respondents, sexual intercourse takes place 
in prison and the possibility of protection against sexually transmitted diseases is 
low. Of the 81% of respondents who were tested for infectious diseases during VTOS, 
48% of respondents suffered from an infectious disease, most often hepatitis C. The 
possibilities of preventing infectious diseases in the prison environment appear to be 
insufficient. There is interest in substitution treatment, but it is little offered [22].
17.  Conceptual and strategic basis of access to imprisoned drug users in 
the world and in the Czech Republic
During the Special Session of the UN General Assembly (UNGASS) in 2016 
was approved the document “Our common commitment to tackling and tackling 
the world drug problem effectively mu “(Our joint commitment to effectively 
addressing and countering the world drug problem). United Nations Standard 
Minimum Rules for the Treatment of Prisoners Minimum Rules for the Treatment of 
Prisoners), the so-called Mandel Rules13, that health care services should be orga-
nized in close relation to public health care and in a way that ensures the continuity 
of treatment and care, including drug treatment The World Health Organization 
(WHO) adopted a Position Paper on Prisons in 2004, drugs and harm reduction 
(Status Paper on Prisons, Drugs and Harm Reduction). This document follows 
on from the Joint Statement of the WHO and the Pompidou Group of the Council 
Prisons, Drugs and Society of 2001. Document identified as one of the main princi-
ples of providing services to imprisoned users drug comparability of health services 
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in prison and at large - the so-called principle of equivalence. A separate section of 
the WHO Prisons and Health document is devoted to drug use and treatment of 
prison addiction. The basic rule in this area is to respect the goal of drug services 
in prisons, which is a precondition for prisoners to leave prison healthier than they 
were when they started serving their sentences [23]. Prisoners should be psychoso-
cially stabilized at the end of their sentences and their treatment should continue 
after release. The issue of the treatment of drug users in prison is also addressed in 
its documents by the United Nations Office on Drugs and Crime (UNODC). In his 
publication Drug Dependence Treatment: Interventions for Drug Users in Prison 
summarizes the findings and examples of good practice in this area [24].
18. New development of the National Drug Strategy in Europe
4 EU Member States (Czech Republic, Estonia, Hungary, Finland), Turkey and 
Norway adopted new drug action plans in the second half of 2007. The documents 
cover a period of 3–4 years and, with the exception of the Turkish action plan, were 
preceded by other plans or programs. In 2007, Spain adopted a complementary 
national action program against cocaine (2007–2010). In 2008, 3 more Member 
States adopted new policy documents. The first Italian Drugs Action Plan has a time 
frame of one year, followed by a four-year Action Plan (2009–2012), which will be 
synchronized with the new EU Drugs Action Plan. Malta’s first national drug docu-
ment does not set a timeframe of almost 50 measures. The new 10-year UK drugs 
strategy (2008–2011) is complemented by a three-year action plan (2008–2011) 
setting out key actions [25].
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
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